KIRSTEN RIVAS-ANDREWS: Open Payments
NPI 1265933717 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 15 payments from 9 companies in 2025. Trend: 2023 $537 · 2024 $209 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 2 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| C2N Diagnostics, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: Xeomin, Kerendia, AIRSUPRA, FANAPT, PRECIVITYAD2, TRELEGY ELLIPTA, M-M-R II, YUPELRI.
Industry payments across AZ — which companies pay providers there.
